Michael A. Secinaro

Michael A. Secinaro, PhD, is a Scientist II at Universal Cells, with experience leading pre-clinical NK cell therapy program development and contributing to major program milestones. Prior roles include Scientist I at Universal Cells, focusing on the characterization of NK cell therapies, and a Postdoctoral Fellow at AstraZeneca, where research involved studying tumor immunosuppressive mechanisms. A Graduate Student Researcher at The Robert Larner, M.D. College of Medicine, Michael made significant contributions to immunology and cell metabolism research. Early career experience includes an internship at Brigham and Women's Hospital, studying cardiovascular disease. Michael holds a PhD in Cell, Molecular, and Biomedical Sciences from The Robert Larner, M.D. College of Medicine and a BS in Molecular and Cell Biology from the University of Connecticut.